1. Home
  2. PDLB vs CRDF Comparison

PDLB vs CRDF Comparison

Compare PDLB & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$16.88

Market Cap

405.9M

Sector

N/A

ML Signal

HOLD

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$3.20

Market Cap

142.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
CRDF
Founded
1960
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
405.9M
142.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
PDLB
CRDF
Price
$16.88
$3.20
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.63
AVG Volume (30 Days)
105.5K
1.0M
Earning Date
01-27-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
142.83
N/A
EPS
0.89
N/A
Revenue
$96,252,000.00
$501,000.00
Revenue This Year
$10.97
N/A
Revenue Next Year
$8.59
N/A
P/E Ratio
$19.00
N/A
Revenue Growth
26.04
N/A
52 Week Low
$10.88
$1.90
52 Week High
$18.01
$4.99

Technical Indicators

Market Signals
Indicator
PDLB
CRDF
Relative Strength Index (RSI) 60.81 80.94
Support Level $16.87 $2.32
Resistance Level $17.48 $2.95
Average True Range (ATR) 0.43 0.17
MACD -0.00 0.08
Stochastic Oscillator 53.81 94.78

Price Performance

Historical Comparison
PDLB
CRDF

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: